Effects of aging β-amyloid on the properties of brain synaptic and mitochondrial membranes

Journal of Neurology

Volumn 248, Issue 9, 2001, Pages 1051-1064

  Eckert, G P ^a   Wood, W G ^b   Muller W E ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Aging; Alzheimer's disease; Amyloid; Brain; Cholesterol; Fluidity; Membrane

Indexed keywords

AMYLOID BETA PROTEIN; CHOLESTEROL; FATTY ACID; FLUORESCENT DYE; PYRENE;

AGE DISTRIBUTION; AGING; ANIMAL MODEL; ANIMAL TISSUE; ANISOTROPY; ARTICLE; CELL MEMBRANE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYNAPSE;

EID: 0034862983     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Effect of proteolysis on the state of lipid phase in rat brain synaptosomal membranes
2. A rapid and sensitive micro-assay for the enzymatic determination of plasma and lipoprotein cholesterol
3. Amyloid beta-peptides increase annular and bulk fluidity and induce lipid peroxidation in brain synaptic plasma membranes
4. The effect of membrane cholesterol content on ion transport processes in plasma membranes
5. Mitochondrial involvement in Alzheimer's disease
6. Bcl-2 protects isolated plasma and mitochondrial membranes against lipid peroxidation induced by hydrogen peroxide and amyloid beta-peptide
7. Amyloid beta-peptide-associated free radical oxidative stress, neurotoxicity, and Alzheimer's disease
8. Beta-Amyloid fragment 25-35 selectively decreases complex IV activity in isolated mitochondri
9. Lipid peroxidation contributes to age-related membrane rigidity
10. Brain synaptosomal aging: Free radicals and membrane fluidity
11. Cholesterol modulates the membrane-disordering effects of beta-amyloid peptides in the hippocampus: Specific changes in Alzheimer's disease
12. Differential effects of lovastatin treatment on brain cholesterol levels in normal and Apo E deficient mice
13. The role of cholesterol in the biosynthesis of beta-amyloid
14. Aging and caloric restriction affect mitochondrial respiration and lipid membrane status: An electron paramagnetic resonance investigation
15. Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity
16. Abnormalities of mitochondrial enzymes in Alzheimer disease
17. Apolipoprotein E and cholesterol affect neuronal calcium signalling: The possible relationship to beta-amyloid neurotoxicity
18. β-amyloid amplifies PLC activity and Ca2+ signalling in fully differentiated brain cells of adult mice
19. Intracellular biology of Alzheimer's disease amyloid beta peptide
20. Inhibition of the electrostatic interaction between beta-amyloid peptide and membranes prevents beta-amyloid-induced toxicity
21. The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution
22. Increasing age alters transbilayer fluidity and cholesterol asymetry in synaptic plasma membrane of mice
23. Location of diphenylhexatriene (DPH) and its derivatives within membranes: Comparison of different fluorescence quenching analyses of membrane depth
24. Amyloid beta peptide membrane perturbation is the basis for its biological effects
25. Amyloid beta-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons
26. Correlation of beta-amyloid aggregate size and hydrophobicity with decreased bilayer fluidity of model membranes
27. Thioflavin T interaction with synthetic Alzheimer's disease beta-amyloid peptides: Detection of amyloid aggregation in solution
28. Protection against amyloid beta peptide toxicity by zinc
29. Protein measurement with the folin phenol reagent
30. Distribution and fluidizing action of soluble and aggregated amyloid beta - Peptide in rat synaptic plasma membranes
31. Calcium-destabilizing and neuro-degenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF
32. Pathological proteins in senile plaques
33. Membrane disruption by Alzheimer beta-amyloid peptides mediated through specific finding to either phospholipids or gangliosides - Implications for neurotoxicity
34. Membrane viscosity correlates with alpha 1-adrenergic signal transduction of the aged rat cerebral cortex
35. β-amyloid peptide decreases membrane fluidity
36. Effects of β-amyloid peptides on the fluidity of membranes from frontal and parietal lobes of human brain. High potencies of A beta 1-42 and A beta 1-43
37. Mitochondrial enzyme expression in the hippocampus in relation to Alzheimer-type pathology
38. Mitochondrial function impairment induced by amyloid beta-peptide on PC12 cells
39. Aggregation-related toxicity of synthetic beta-amyloid protein in hippocampal cultures
40. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model
41. Modulation of ATPase activities of human erythrocyte membranes by free fatty acids or phospholipase A2
42. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons
43. Age-related structural and functional changes of brain mitochondria
44. Age-related differences in synaptosomal peroxidative damage and membrane properties
45. Changes in lipid composition of cortical synaptosomes from different age groups of mice
46. Acute and chronic effects of ethanol on transbilayer membrane domains
47. Cholesterol oxidation reduces Ca(2+)+MG (2+)-ATPase activity, interdigitation, and increases fluidity of brain synaptic plasma membranes
48. Recent advances in brain cholesterol dynamics: Transport, domains, and Alzheimer's disease
49. Amyloid beta protein starts to deposit as plasma membrane-bound form in diffuse plaques of brains from hereditary cerebral hemorrhage with amyloidosis - Dutch type, Alzheimer disease and nondemented aged subjects
50. Neurotrophic and neurotoxic effects of amyloid - Beta protein: Reversal by tachykinin neuropeptides
51. Cholesterol protects PC12 cells from beta-amyloid induced calcium disordering and cytotoxicity